Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated (CORT)

Market Open
25 Feb, 15:11
NASDAQ (CM) NASDAQ (CM)
$
36. 72
+0.24
+0.66%
$
3.66B Market Cap
- P/E Ratio
- Div Yield
326,381 Volume
- Eps
$ 36.48
Previous Close
Day Range
35.4 38.22
Year Range
28.66 117.33
Want to track CORT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CORT earnings report is expected in 68 days (4 May 2026)
Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?

Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal

Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal

Corcept's (CORT) phase III GRACE study, evaluating its lead candidate, relacorilant, for treating patients with Cushing's syndrome, meets the primary endpoint in a randomized withdrawal phase.

Zacks | 1 year ago